Akeso's Breakthrough Drugs Secure Inclusion in China's NRDL, Enhancing Patient Treatment Options #China #Hong_Kong #Akeso #Ivonescimab #Ebronucimab
1
0
0
0
Akeso's Breakthrough Drugs Secure Inclusion in China's NRDL, Enhancing Patient Treatment Options #China #Hong_Kong #Akeso #Ivonescimab #Ebronucimab
China NMPA Approves Ebronucimab Injection for Hypercholesterolemia Treatment
๐ฉ info@dengyuemed.com
๐https://dengyuemed.com
#Ebronucimab #PCSK9Inhibitor #CholesterolTreatment #NMPAApproval #ChineseBiologics #Hypercholesterolemia #CardiovascularHealth #KangrongDongfang